Search Results 771-780 of 18303 for prostate cancer
Previous or concurrent malignancy other than non-melanoma skin cancer within 5 years of diagnosis of prostate cancer; Inability to start the protocol ...
ethral incision of the prostate, Benign prostatic hyperplasia, Prostate cancer, Bladder cancer, Kidney stone, Bladder stones. Show more areas of focus for ...
About this study. A Phase 2, 2 part trial to evaluate the safety and efficacy of galeterone in castration resistant prostate cancer (CRPC) patients.
... prostate cancer. This collaboration is a direct result of the 2023 Strategic Radiology Research Alliance between Mayo Clinic and GE HealthCare, aimed at ...
After John Sullivan experienced the benefits of a Choline C-11 PET scan when he had a recurrence of prostate cancer, he and his fiancée, Sheri Butler, were ...
... prostate cancers. ... If you take estrogen-related drugs, such as those used for hormone therapy for prostate cancer, your risk of breast cancer is increased.
... Prostate Cancer. Print details. Share; Facebook · Twitter. Overview; Participation eligibility; Participating Mayo Clinic info; More information. Overview. Tab ...
This medicine will not prevent prostate cancer but may increase your risk of developing high-grade prostate cancer. Tell your doctor if you have concerns ...
Recurrent and advanced urologic cancers · Bladder cancer: urine markers/treatment/surgery including reconstruction and replacement · Prostate cancer including ...
Ram A. Pathak, M.D., is a urologic oncologist at Mayo Clinic in Jacksonville, Florida specializing in prostate cancer diagnosis, MRI-guided biopsy, ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.